Evaluation of the in vitro activity of cefepime compared to other broad- spectrum cephalosporins against clinical isolates from eighteen brazilian hospitals by using the etest

Diagnostic Microbiology and Infectious Disease

Volumn 28, Issue 2, 1997, Pages 87-92

  Sader, Helio S ^a   Mimiça, Igor ^b   Rossi, Flávia ^c   Zoccoli, Cássia ^d   Montelli, A C ^e   Sampaio, Jorge L M ^f   Segura, Adília J A ^g   Magalhães, Marcelo ^h   Nowakonski, Angela ⁱ   Mendes, Caio M F ^j  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b S Casa de Misericordia de S Paulo   (Brazil)

^c Hospital Emilio Ribas   (Brazil)

^d Santa Luzia Medical Laboratory   (Brazil)

^e SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^f Lamina Laboratory   (Brazil)

^g Hospital Universitario de Brasilia   (Brazil)

^h Marcelo Magalhães Lab   (Brazil)

ⁱ UNIVERSITY OF CAMPINAS   (Brazil)

^j UNIVERSITY OF SÃO PAULO   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; BRAZIL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE COCCI; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

BACTERIA; CEPHALOSPORINS; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS;

EID: 0030793756     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00015-1     Document Type: Article

References (15)

1. Barradell LB, Bryson HM (1994) Cefepime. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use. Drugs 47:471-505.
2. Frei R, Jones RN, Pignatari AC, Yamane N, Marco F, Hoban DJ (1994) Antimicrobial activity of FK-037: A new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime. Diagn Microbiol Infect Dis 18:167-173.
3. Fuchs PC, Jones RN, Barry AL, Thornsberry C (1985) Evaluation of the in vitro activity of BMY-28142: A new broad-spectrum cephalosporin. Antimicrob Agents Chemother 27:679-682.
4. Gales AC, Sader HS, Machado AMO, Jones RN, Pignatari AC (1995) Comparação das atividades antimicrobianas da cefepime e da ceftazidima em 1015 amostras bacterianas isoladas em São Paulo. J Bras Patol 31:55-60.
5. Jacoby GA, Han P (1996) Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae-and Escherichia coli. J Clin Microbiol 34:908-911.
6. Jones RN, Kerhberg EN, Erwin ME, Anderson SC. The Fluoroquinolone Resistance Surveillance Group (1994) The prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States: Study on the threat of emerging resistance, real or perceived? Diag Microbiol Infect Dis 19:203-215.
7. Martínez-Martínez L, Hernández-Alléz S, Albertí S, Tomás JM, Benedi VJ, Jacoby GA (1996) In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and extended-spectrum cephalosporins. Antimicrob Agents Chemother 40:342-348.
8. National Committee for Clinical Laboratory Standards (NCCLS) (1993) Performance standards for antimicrobial disk susceptibility tests: approved standard M2-A5. 5th edition. Villanova, PA: NCCLS.
9. Novak SM (1994) Etest susceptibility testing. In Clinical Microbiology Procedures Handbook, Ed D Isenberg. Washington, DC: American Society for Microbiology, suppl. 1, pp. 5.a.1-17.
10. Phelps DJ, Carlton DD, Farrel CA, Kessler RE (1986) Affinity of cephalosporins for β-lactamases as a factor in antibacterial efficacy. Antimicrob Agents Chemother 29: 845-848.
11. Sader HS, Jones RN (1992) Historical overview of the cephalosporin spectrum: Four generations of structural evolution. Antimicrob Newslett 8:75-82.
12. Sanchez ML, Jones RN (1993) Etest, an antimicrobial susceptibility testing method with broad clinical and epidemiology application. Antimicrob Newslett 8:1-5.
13. Sanders CC (1993) Cefepime: The next generation? Clin Infect Dis 17:369-379.
14. Sanders WE Jr, Tenney JH, Kessler RE (1996) Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin Infect Dis 23:454-461.
15. Washington JA, Jones RN, Gerlach EH, Murray PR, Allen SD, Knapp CC (1993) Multicenter comparison of in vitro activities of FK-037, cefepime, ceftriaxone, ceftazidime, and cefuroxime. Antimicrob Agents Chemother 37:1696-1700.